Friday Flicks: Is Terrence Malick’s ‘To the Wonder’

New Post Public Reply Private Reply Replies (0) Message Board
testuser
Friday Flicks: Is Terrence Malick’s ‘To the Wonder’ Wonderful? To the Wonder It says much about how highly regarded was the legendary film critic Roger Ebert, who sadly passed away last week at the age of 70, that his final ever review is generating publicity. The film is Terrence Malick’s To the Wonder, which tells the story of Marina (Olga Kurylenko) and Neil (Ben Affleck), who meet in France and move to Oklahoma to start a life together. Marina becomes friends with a priest and fellow expatriate (Javier Bardem), while Neil rekindles a relationship with childhood sweetheart, Jane (Rachel McAdams). In a directorial career stretching some 40 years, it’s incredible to think that this is only Malick’s sixth feature (although along with Tree of Life and The New World, it’s the 69-year-old’s third movie in less than a decade). To be sure, the movie isn’t eliciting rave reviews from everyone. TIME’s Richard Corliss manages to see both sides of the debate. “For spectators dulled by the midget movies of an artistically timid era, the film may be a chore. For those on Malick’s rarified wavelength, it’s a wonder,” he concludes. But New York magazine calls the film ”generalized woo-woo — and self-parody” while the Observer turns up its nose, noting that ”the characters have little substance or development” and the “dialogue is minimal and deliberately semi-audible.” Meanwhile, the Daily Mail delivers an outright pan, calling the film ”a prolonged exercise in directorial self-pleasuring;” the real wonder, it states, is ”that To The Wonder ever found a release.” But if there was one thing we could rely on when it came to Ebert, it was his refusal to run with the crowd. In an unabashed thumbs up, his final words both acknowledge Malick’s faults while embracing the film as a whole. There will be many who find “To the Wonder” elusive and too effervescent. They’ll be dissatisfied by a film that would rather evoke than supply. I understand that, and I think Terrence Malick does, too. But here he has attempted to reach more deeply than that: to reach beneath the surface, and find the soul in need. RICHARD CORLISS ON ROGER EBERT: Farewell to a
Investors-Hangout-Stock-Message-Boards-thumbnail-2015.png

test123 kjk
Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

TCTM KIDS IT Education Inc. Announces 2024 Annual Report

Updated Category News Views 322

TCTM KIDS IT Education Inc. Issues 2024 Annual Report TCTM KIDS IT EDUCATION INC. (NASDAQ: VSA), a prominent leader in IT-focused supplementary STEM education, has officially filed its annual report on Form 20-F for the fiscal year ending December 31, 2024, with the Securities and Exchange Commission (SEC). This filing reflects the company’s ongoing commitment to...

Continue Reading
Polaris Celebrates Commitment to Community and Environment

Updated Category News Views 224

Polaris Revolutionizes Commitment Through Geared For Good Report Polaris continues to ensure sustainability and responsible stewardship across its operations, supporting its employees, riders, communities, and the environment. The recently released report illustrates Polaris Inc.'s (NYSE: PII) dedication to these values. Impacting Lives Through Corporate Responsibility...

Continue Reading
AgentCoach.AI Transforms Real Estate Coaching with AI Tools

Updated Category News Views 195

AgentCoach.AI Revolutionizes the Coaching Landscape Real Estate Professionals Gain Access to On-Demand Expertise and Tools for a Fraction of Traditional Coaching Costs AgentCoach.AI is excited to introduce its innovative AI-powered coaching platform tailored specifically for real estate agents. This groundbreaking service is designed to streamline everyday tasks, enhance...

Continue Reading
Unleash Creativity: LEGO's 2025 Workshop Series for Kids

Updated Category News Views 460

LEGO Group Launches Exciting 2025 Creativity Workshop Series The LEGO Group is thrilled to introduce its innovative 2025 Creativity Workshop Series, offering young creators a fantastic opportunity to unleash their imagination. Tailored for children aged 6 to 12, these engaging workshops will take place at select LEGO stores, providing both in-person and online...

Continue Reading
Kering Overview: Enhanced Share Liquidity Insights for Growth

Updated Category News Views 132

Kering Overview: Enhanced Share Liquidity Insights for Growth Kering has recently shared a detailed report on its share liquidity mandate which outlines the company's achievements during the first half of the year. This report sheds light on the performance and trading activity of Kering shares as per its engagement with Rothschild Martin Maurel. There is an evident...

Continue Reading